Latest News

March 21, 2022

SQZ Biotechnologies Announces $2 Million Grant From the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson’s Disease

March 16, 2022

SQZ Biotechnologies Reports Full Year 2021 Financial Results and Recent Portfolio Updates

March 08, 2022

SQZ Biotechnologies to Present New Enhanced APC Platform Preclinical Findings and ENVOY-001 Phase 1/2 Clinical Trial in Progress Poster at the American Association for Cancer Research 2022 Annual Meeting

View All News

Join The Team

Learn More